bioRxiv preprint doi: https://doi.org/10.1101/721480; this version posted August 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 Bivalent and Broad Chromatin Domains Regulate Pro-metastatic Drivers in 2 Melanoma 3 Christopher Terranova#,1, Ming Tang#,1,10, Mayinuer Maitituoheti#,1, Ayush T. Raman1,7,8, 4 Jonathan Schulz1, Samir B. Amin1,6, Elias Orouji1,11, Katarzyna Tomczak1, Sharmistha 5 Sarkar1, Junna Oba3, Caitlin Creasy3, Chang-Jiun Wu1, Dongyu Zhao9, Kaifu Chen9, 6 Lauren E. Haydu5, Wei-Lien Wang2, Alexander J. Lazar2, Scott E. Woodman1,3,4, 7 Chantale Bernatchez3, and Kunal Rai1,* 8 1 Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 9 Houston, TX. 10 2 Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 11 TX. 12 3 Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer 13 Center, Houston, TX. 14 4 Department of Systems Biology, University of Texas MD Anderson Cancer Center, 15 Houston, TX. 16 5 Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. 17 6 The Jackson Laboratory for Genomic Medicine, Farmington, CT. 18 7 Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA. 19 8 Graduate Program in Quantitative Sciences, Baylor College of Medicine, Houston, TX. 20 9 Institute for Academic Medicine, Methodist Hospital Research Institute, Houston, TX. 21 10 FAS informatics, Department of Molecular Biology, Harvard, Cambridge, MA 22 11 Epigenetics Initiative, Princess Margaret Genomics Centre, Toronto, ON Canada 23 *Corresponding Author:
[email protected] 24 bioRxiv preprint doi: https://doi.org/10.1101/721480; this version posted August 1, 2019.